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424Objective: Percutaneous valve replacements are presently being evaluated in clinical trials. As delivery of the
valve is catheter based, the safety and efficacy of these procedures may be influenced by the imaging used. To
assist the surgeon and improve the success of the operation, we have performed transapical aortic valve replace-
ments using real-time magnetic resonance imaging guidance.
Methods: Twenty-eight swine underwent aortic valve replacement by real-time magnetic resonance imaging on
the beating heart. Stentless bioprostheses mounted on balloon-expandable stents were used. Magnetic resonance
imaging (1.5 T) was used to identify the critical anatomic landmarks. In addition to anatomic confirmation of ad-
equate placement of the prosthesis, functional assessment of the valve and left ventricle and perfusion were also
obtained with magnetic resonance imaging. A series of short-term feasibility experiments were conducted
(n¼ 18) in which the animals were humanely killed after valve placement and assessment by magnetic resonance
imaging. Ten additional animals were allowed to survive and had follow-up magnetic resonance imaging scans
and confirmatory echocardiography at 1, 3, and 6 months postoperatively.
Results: Real-time magnetic resonance imaging provided superior visualization of the landmarks needed. The
time to implantation after apical access was 74 18 seconds. Perfusion scanning demonstrated adequate coronary
flow and functional imaging documented preservation of ventricular contractility in all animals after successful
deployment. Phase contrast imaging revealed minimal intravalvular or paravalvular leaks. Longer term results
demonstrated stability of the implants with preservation of myocardial perfusion and function over time.
Conclusions:Real-timemagnetic resonance imaging provides excellent visualization for intraoperative guidance
of aortic valve replacement on the beating heart. Additionally, it allows assessment of tissue perfusion and organ
function that is not obtainable by conventional imaging alone. (J Thorac Cardiovasc Surg 2010;139:424-30)Valve replacement in the beating heart using either a percu-
taneous or left ventricular apical access has been reported.1-9
These minimally invasive approaches reduce trauma and
speed recovery for the patient. Compared with the percuta-
neous transfemoral approach, transapical aortic valve re-
placement provides a direct and short access to the native
valve. It requires general anesthesia, but this approach
may be more applicable to a wider range of patients because
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The Journal of Thoracic and Cardiovascular Surgtransapical approach permits the potential implantation of
a conventional prosthesis that has a known durability and
proven success rate.
Typically, the imaging used for percutaneous valve place-
ment is fluoroscopy, which provides 2-dimensional visuali-
zation with little soft tissue contrast. Contrast agents must be
repeatedly injected to determine the location of the aortic an-
nulus and coronary ostia. The patient and physician are ex-
posed to radiation during the intervention. Rapid ventricular
pacing to unload the ventricle, which is considered funda-
mental for the success of the procedure, has precipitated car-
diac arrest in some high-risk patients. Moreover, additional
imaging and expertise with echocardiography is required
for postintervention valvular assessment.
Magnetic resonance imaging (MRI) provides better ana-
tomic detail than fluoroscopic or echocardiographic imaging
without additional risk of radiation and contrast reaction. As
a result of the clarity of MRI, image interpretation is easy for
anyone familiar with the surgical anatomy. The develop-
ment of real-time MRI allows this imaging modality to pro-
vide intraoperative guidance for delivery of prosthetic aortic
valves.10,11 MRI also provides the ability to assess results,
such as ventricular and valvular function and myocardial
perfusion immediately after intervention. To demonstrateery c February 2010
Abbreviations and Acronyms
Gd-DTPA ¼ gadolinium with diethylenetriamine
penta-acetic acid
MR ¼ magnetic resonance
MRI ¼ magnetic resonance imaging
Horvath et al Evolving Technology/Basic Sciencehow real-time MRI can assist the surgeon and improve the
success of the operation, we have performed transapical aor-
tic valve replacement using real-time MRI guidance. We re-
port our real-time MRI-guided transapical aortic valve
experiment technique and its midterm results.
MATERIALS AND METHODS
Imaging System, Prosthetic Valve, and Devices
A 1.5 T Magnetom Espree MRI (Siemens Medical Solutions, Munich,
Germany) was used for the intervention. This magnet design, with a short
(120 cm) and wide (70 cm) bore, makes surgical access to the patient within
the magnet feasible. High-quality images can be obtained at 5 to 10 frames
per second with low latency. In addition to providing standard MR se-
quences, a fully interactive, real-time MRI system connected to the scanner
provides a real-time interactive imaging sequencing.12,13 This system com-
prises an interactive user interface, an operating room large-screen display,
gated pulse sequences, and image reconstruction software. Multiple oblique
slices can be obtained in rapid succession and can be simultaneously dis-
played in a 3-dimensional rendering to provide optimal 3-dimensional ana-FIGURE 1. Bioprosthesis mounted on a platinum–iridium stent. A stainless ste
marker is visible as a dark signal in the MRI and indicates the orientation of the p
a passive marker under real-time MRI are shown in parts C and D, respectively. I
ostia and the yellow dot is the digital marker of the aortic annulus location.
The Journal of Thoracic and Catomic information. Image contrast, image plane orientations, acquisition
speed, 3-dimensional rendering, and device tracking can be readily adjusted
as needed during scanning. Standard MR sequences are used for preopera-
tive surgical planning and postplacement evaluation; in between this stan-
dard scanning, real-time MRI provides feedback on the progress of the
procedure.
Since the intervention is performed in the MRI scanner, the instru-
ments and materials must be compatible with the magnetic field. Commer-
cially available 21- to 25-mm stentless bioprostheses (Toronto SPV; St
Jude Medical, Inc, Minneapolis, Minn; or Freestyle aortic root bioprosthe-
sis; Medtronic, Inc, Minneapolis, Minn) were selected on the basis of the
aortic valve size scanned with MRI. These bioprosthetic valves were
mounted on an analogous-sized, platinum–iridium stent (Cheatham Plati-
num; NuMed, Hopkinton, NY). Small austenitic stainless steel fragments
(0.2 mm) were welded on the side of the stent between the bioprosthetic
valve commissures. This paramagnetic marker is visible as a dark signal
in the MRI and is used to indicate the orientation of the valve/stent.
The bioprosthesis and stent were then circumferentially compressed
over 2-stage balloon-tipped catheters (NuMed, 25-30 mm outer diameter,
50 mm long). Figure 1 shows a Medtronic valve mounted on a NuMed
platinum–iridium stent and its MR image. A central guidewire allowed
tracking of the balloon-tipped catheter antegradely across the native aortic
valve.
The delivery device consists of a straight plastic rod, outside of which is
a sheath protecting the bioprosthetic valve before it is deployed. The length
of the delivery device is 60 cm. The diameter of the delivery device is 9.5
mm and it fits into a 10-mm trocar. The inner rod has a 6.35-mm central
channel for the guidewire-directed balloon-tipped catheter. At the distal
end of the inner rod, a locking system is used to prevent relative motion be-
tween the catheter and the rod itself. The translation and rotation of the rod
directly relate to the translation and rotation of the balloon catheter. Theel marker welded on the side of the stent between the commissures (A). The
rosthesis (B). The short-axis view and long-axis view of the prosthesis with
n parts C and D, 2 blue dots are the digital markers that indicate the coronary
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FIGURE 2. Real-time MRI provided superior visualization for implanting
the aortic valve prosthesis. Snapshots showmultiple image planes displayed
at their relative 3-dimensional position. The 3-dimensional rendering pro-
vides 3-dimensional anatomic information.
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gasket is used to prevent blood leakage from the central channel.
Preoperative Preparation
All experiments were performed under protocols approved by the Na-
tional Institutes of Health Animal Care and Use committee. After induction,
28 domestic pigs were intubated and anesthetized. Standard MR sequences
were performed to obtain the orientation of the heart, evaluate ventricular
and valve function, and locate the native valve annulus and the origin of
the coronary arteries. By use of standard titanium surgical instruments via
a 6-cm subxiphoid incision, the pericardium was opened and the apex of
the heart was exposed. Two concentric purse-string sutures were placed
around the apex, through which a 10-mm trocar (Ethicon Surgical Inc, Som-
erville, NJ) was inserted into the left ventricle. Typical time to complete this
part of the procedure was 15 to 20 minutes.
Pre-scanning also allows setting up scan planes to be used for real-time
imaging during valve implantation and follow-up myocardial perfusion and
aortic flow imaging. Three imaging planes were prescribed for real-time im-
aging during implantation. Two of these planes were positioned to provide
long-axis views of the left ventricle, showing the right coronary artery and
left anterior descending coronary artery origins, respectively. The other
plane provided an axial view of the aortic valve. The coronary ostia and aor-
tic annulus location were digitally marked. These digital marks remained
visible at all times in the 3-dimensional rendering and were used for ana-
tomic reference.
Valve Implantation
The surgeon views the real-time imaging on a projection screen while
manipulating the deployment device within the animal in the magnet.
Three snapshots of the real-time MRI with multiple image planes are shown
in Figure 2.
A guidewire is advanced through the trocar across the native aortic valve,
after which the prosthetic valve and delivery system are advanced through
the trocar. During implantation, the axial slice is shifted as needed to visu-
alize the device and guide proper orientation of commissures with the help
of the passive marker. The long-axis views are interactively modified to
show the path of the delivery device, while keeping the coronary origins
in view. The surgeon is in contact with the scanner operator by means of
headphones and a microphone (Magnacoustics, Atlantic Beach, NY) to re-
quest changes in the imaging planes as needed.
Once in place, the balloon is partially inflated by using normal saline
mixed 100:1 with an MR contrast agent, gadolinium with diethylenetri-
amine penta-acetic acid (Gd-DTPA; Magnavist, Berlex Inc, Montville,
NJ). The position is reconfirmed to be ideal, and the balloon is then fully
expanded and the valve/stent deployed while monitoring with the real-
time MRI. The balloon is then deflated. The catheter and guidewire are re-
moved through the trocar. Ventricular function is immediately assessed with
the real-time imaging.
During the procedure, the animals were monitored with an electrocardio-
gram, oxygen saturation, end-tidal carbon dioxide, systemic and left ventric-
ular blood pressure, and arterial blood gas analysis.
Postplacement Validation
After placement of the valve, the trocar was removed and the apex closed
with the purse-string sutures. Postplacement images were acquired to con-
firm the positions of the prostheses and the valvular and heart function. In
addition to anatomic confirmation of adequate placement of the prosthetic
valve in relation to the aortic annulus and the coronary arteries, functional
assessment of the valve and left ventricle was also obtained with MRI.
Gated cine-MRI was used to assess mitral valve function and myocardial
function. Phase contrast cine-MRI was used to identify flow through the
new valve as well as intravalvular or paravalvular regurgitation. An MR
first-pass perfusion scan14 was performed during intravenous injection of426 The Journal of Thoracic and Cardiovascular Surgery c February 2010
FIGURE 3. Long-term follow-up MRI scans at 1, 3, and 6 months postoperatively.
Horvath et al Evolving Technology/Basic Science
The Journal of Thoracic and Cardiovascular Surgery c Volume 139, Number 2 427
E
T
/B
S
TABLE 1. The ventricular and valvular results
LVDD (mm) AV root (mm) EF (%) AV peak gradient AV mean gradient
1 mo 43  10 28  1.1 63  4.1 9.3  3.1 4.4  1.5
3 mo 45  9.9 27  1.5 64  2.2 15.0  5.7 7.3  3.1
6 mo 47  9.9 27  1.9 64  3.8 12.0  5.2 5.6  2.6
ANOVA P value .817 .688 .912 .133 .144
Measurements were based on magnetic resonance imaging and confirmatory echocardiographic data. LVDD, Left ventricular diastolic dimension; AV, aortic valve; EF, ejection
fraction; ANOVA, analysis of variance.
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to all segments of the myocardium.
Experimental Follow-up
A series of short-term feasibility experiments was conducted (n¼ 18) in
which the animals were humanely killed after valve placement and MRI as-
sessment. Ten additional animals were allowed to survive for long-term fol-
low-up. At 1 and 3 months postoperatively, follow-up MRI scans and
transthoracic echocardiograms were acquired while at 6 months postopera-
tively MRI scans and confirmatory 2- and 3-dimensional transesophageal
echocardiograms were acquired. Retrospectively, gated cine-MR, phase-
contrast cine-MR, and MR first-pass perfusion scanning during intravenous
injection of Gd-DTPA contrast agent were repeated at those time points to
confirm the position of the prostheses and the valvular and heart function.
RESULTS
Real-time MRI provided better visualization of the land-
marks needed to implant the aortic valve prostheses than
fluoroscopy or echocardiography. The passive marker on
the stent is a superb indicator of the valve orientation in
MRI at the time of placement and can be used to determine
whether the valve migrates over time. The time to implanta-
tion after the apical access was obtained to deployment of
the valve was 74 18 seconds. This includes the time to cor-
rectly orient the prosthetic valve with respect to the native
annulus and the coronary ostia. The average procedure dura-
tion from skin incision to closure including scanning was
less than 40 minutes.
Retrospectively gated cine-MRI revealed excellent myo-
cardial function after valve implantation in both long- and
short-axis views (snapshot is shown in Figure 3, column 1,
row 1 and row 2). The phase-contrast cine-MRIs (Figure 3,FIGURE 4. Aortic valve and mitral valve regurg
428 The Journal of Thoracic and Cardiovascular Surgcolumn 1, row 3) show the through-plane blood velocity in
both systole and diastole. These images confirm good
systolic flow with excellent valve leaflet opening and no
evidence of turbulence, diastolic regurgitant flow, or para-
valvular leak. First-pass perfusion studies demonstrated ad-
equacy of myocardial blood flow after valve placement in all
animals after successful deployment. A first-pass perfusion
scan at the base of the heart after valve implantation is shown
in Figure 3, column 1, row 4. These perfusion results con-
firm adequacy of blood flow at the tissue level, indicating
proper valve positioning with respect to the coronary ostia.
Echocardiographic results confirmed the MRI findings and
further documented the stability of prosthesis position and
function over time. Necropsy of all these animals confirmed
the deployed prosthetic valve location with respect to the
aortic annulus and the mitral valve, and the commissures
did not obstruct the coronary ostia. The observed distances
between the commissural marker and a coronary ostium
were 4 mm or greater. These necropsy findings verified
the MRI and echocardiography results.
Among 10 animals allowed to survive, 7 survived for 6
months. Three animals died between 1 and 2 weeks postop-
eratively of respiratory complications. The 7 long-term sur-
vivors were brought back for echocardiography and MRI
scan 1, 3, and 6 months after the procedure. Figure 3 shows
long-term follow-up MRI scan for a pig at 1, 3, and 6
months, with regard to anatomic positioning, phase contrast,
and perfusion. In the follow-up studies, perfusion scanning
demonstrated adequate coronary flow and functional imag-
ing documented preservation of ventricular contractility.itation of 7 animals with long-term survival.
ery c February 2010
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paravalvular leaks. The ventricular and valvular parameters
of 7 animals based on 1, 3, and 6months’ follow-up echocar-
diograms andMRI scan are presented in Table 1. Analysis of
variance was performed to determine the significance of the
differences between the 1-, 3-, and 6-month data. The P
values are also shown in Table 1. From these P values we
can conclude that there is no significant difference among
the ventricular and valvular parameters during the 6 months
after the procedure. The degree of insufficiency of the aortic
valve and the mitral valve over 6 months after the procedure
were measured and shown in Figure 4. Longer term results
demonstrated stability of the implants without migration or
change in position and with preservation of myocardial per-
fusion and function over time. The histopathologic reports of
midterm (6 months) verified that all the implanted aortic
stent and valve assemblies were in place in the aortic root.
The stents were properly seated in firm apposition to the aor-
tic wall from the level of the prosthetic leaflets to the distal
commissures tips. The prosthetic device leaflets remained
cusp shaped and in the closed position exhibited good coap-
tation of the free edges. These necropsy findings correlated
with both the MRI and echocardiographic results. Two ani-
mals grew from 50 kg to 200 kg during the 6-month period
of follow-up; and the aortas partially outgrew the original
implanted aortic stents. At necropsy after 6 months in these
animals, some focal gaps were observed between the device
and the native aortic wall in the area of the native aortic leaf-
let. These gaps allowed for perivalvular regurgitation, which
was noted on MRI and echocardiogram before necropsy.
DISCUSSION
Percutaneous transfemoral aortic valve replacement has
been reported in a highly selected cohort of patients.2 The
percutaneous technique requires excessive minimization of
the prosthesis, which still remains bulky, could result in de-
vice embolization, and is difficult to traverse undersized, cal-
cified, or tortuous iliofemoral vessels.15 Transapical aortic
valve implantation is a relatively easy, safe, and straightfor-
ward direct technique, which allows excellent alignment be-
tween the prosthesis and the aortic root. Patients with
symptomatic, severe aortic stenosis and high surgical risk
are more suitable for the transapical approach.16,17
According to the literature, in both the percutaneous
transfemoral and transapical approaches, positioning of the
prosthesis is mostly aided by 2-dimensional M-mode trans-
esophageal echocardiography and high-resolution fluoros-
copy.7 Fluoroscopy provides little soft tissue contrast.
Additionally, what weakly visible landmarks that the calci-
fication of the stenotic valve provides are lost or distorted af-
ter the mandatory balloon valvuloplasty done before valve
placement. Contrast agents must be frequently injected to
determine the location of the aortic annulus and coronary os-
tia. The patient and physician are exposed to radiation duringThe Journal of Thoracic and Cathe intervention. Echocardiography is dependent on ultra-
sonic beam reflection and therefore is subject to impaired
imaging caused by limited acoustic windows. This is partic-
ularly true for the aortic valve when considering the impact
of calcification and/or prosthesis shadowing. Fusion imag-
ing combining computed tomography and fluoroscopy has
been proposed to overcome these issues but are not real
time, are highly dependent on stable patient registration,
and significantly increase the radiation exposure. Clinical re-
sults of both transfemoral and transapical approaches for
percutaneous aortic valve replacement have reported success
with these techniques. Thus far, these procedures have car-
ried a significant morbidity and mortality. Major adverse
cardiac and cerebrovascular events have been seen in 32%
to 65% of the patients.15 Periprocedural mortality has
ranged from 10% to 23%.18,19 Although some of these out-
comes are due to the comorbidities of the high-risk patients
being treated, many can be attributed to imaging-related
problems including coronary obstruction, myocardial infarc-
tion, device misalignment, and valve embolization. In fact,
valve malposition or migration are two of the top three rea-
sons for procedural failure.20 Other frequently reported lim-
itations that are imaging related include landmark loss after
balloon valvuloplasty, perivalvular leak owing to inability to
determine whether the stent is adequately opposed to the
aorta and aortic annulus, and fatal arrhythmias resulting
from the rapid ventricular pacing required to provide time
for valve placement. These difficulties should be decreased
by improving the imaging used to perform the procedure.
Real-time MRI provides excellent visualization for intra-
operative guidance of aortic valve replacement on the beat-
ing heart. It provides better image quality and a complete
view of the entire chest more than other competing imaging
methods, such as fluoroscopy/angiography, in which some
anatomic structures are not visible, and echocardiography,
in which the field of view is small. MRI-guided surgery
also allows direct functional assessments to be made before,
during, and immediately after valve implantation that are not
obtainable by conventional imaging alone.21
Expansion of real-time MRI guidance to facilitate other
types of cardiac surgical procedures, including mitral, pul-
monary, and tricuspid valve replacements or repairs, should
be considered to minimize trauma and enhance patient
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